SNX2-1-108 is a potent and selective small molecule inhibitor targeting the Mediator complex kinases CDK8 and CDK19. It is a valuable research tool for in vitro studies of transcriptional regulation and has been utilized in investigations of Wnt/beta-catenin signaling and colorectal cancer models.
Molekulargewicht:
324.38
CAS Nummer:
[1366002-73-4]
Formel:
C21H16N4
Target-Kategorie:
CDK,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten